Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Serotonin Neuronal Function from the Bed to the Bench: Is This Really a Mirrored Way?

Etievant A, Lau T, Lucas G, Haddjeri N.

eNeuro. 2019 Jun 5;6(3). pii: ENEURO.0021-19.2019. doi: 10.1523/ENEURO.0021-19.2019. Print 2019 May/Jun. No abstract available.

2.

Asenapine modulates mood-related behaviors and 5-HT1A/7 receptors-mediated neurotransmission.

Delcourte S, Abrial E, Etiévant A, Rovera R, Arnt J, Didriksen M, Haddjeri N.

CNS Neurosci Ther. 2017 Jun;23(6):518-525. doi: 10.1111/cns.12698. Epub 2017 Apr 17.

PMID:
28417559
3.

The antidepressant-like effect of tDCS in mice: A behavioral and neurobiological characterization.

Peanlikhit T, Van Waes V, Pedron S, Risold PY, Haffen E, Etiévant A, Monnin J.

Brain Stimul. 2017 Jul - Aug;10(4):748-756. doi: 10.1016/j.brs.2017.03.012. Epub 2017 Mar 29.

PMID:
28416160
4.

[Astroglial modulation of deep brain stimulation in depression].

Etiévant A, Lucas G, Haddjeri N.

Med Sci (Paris). 2016 8-9;32(8-9):687-9. doi: 10.1051/medsci/20163208009. Epub 2016 Sep 12. French. No abstract available.

5.

Deep Brain Stimulation for Depression: Is It a Gray or White "Matter"?

Etiévant A, Lucas G, Haddjeri N.

Biol Psychiatry. 2016 Sep 15;80(6):e43-e44. doi: 10.1016/j.biopsych.2015.11.029. Epub 2016 Jan 26. No abstract available.

PMID:
26987628
6.

The Role of Astroglia in the Antidepressant Action of Deep Brain Stimulation.

Etiévant A, Lucas G, Dkhissi-Benyahya O, Haddjeri N.

Front Cell Neurosci. 2016 Jan 12;9:509. doi: 10.3389/fncel.2015.00509. eCollection 2015. No abstract available.

7.

Repetitive transcranial magnetic stimulation induces long-lasting changes in protein expression and histone acetylation.

Etiévant A, Manta S, Latapy C, Magno LA, Fecteau S, Beaulieu JM.

Sci Rep. 2015 Nov 20;5:16873. doi: 10.1038/srep16873.

8.

Astroglial Control of the Antidepressant-Like Effects of Prefrontal Cortex Deep Brain Stimulation.

Etiévant A, Oosterhof C, Bétry C, Abrial E, Novo-Perez M, Rovera R, Scarna H, Devader C, Mazella J, Wegener G, Sánchez C, Dkhissi-Benyahya O, Gronfier C, Coizet V, Beaulieu JM, Blier P, Lucas G, Haddjeri N.

EBioMedicine. 2015 Jul 7;2(8):898-908. doi: 10.1016/j.ebiom.2015.06.023. eCollection 2015 Aug.

9.

Protein kinase C inhibition rescues manic-like behaviors and hippocampal cell proliferation deficits in the sleep deprivation model of mania.

Abrial E, Bétourné A, Etiévant A, Lucas G, Scarna H, Lambás-Señas L, Haddjeri N.

Int J Neuropsychopharmacol. 2014 Oct 31;18(2). pii: pyu031. doi: 10.1093/ijnp/pyu031.

10.

Effect of the multimodal acting antidepressant vortioxetine on rat hippocampal plasticity and recognition memory.

Bétry C, Etiévant A, Pehrson A, Sánchez C, Haddjeri N.

Prog Neuropsychopharmacol Biol Psychiatry. 2015 Apr 3;58:38-46. doi: 10.1016/j.pnpbp.2014.12.002. Epub 2014 Dec 16.

PMID:
25524057
11.

Stimulation of 5-HT2C receptors improves cognitive deficits induced by human tryptophan hydroxylase 2 loss of function mutation.

Del'Guidice T, Lemay F, Lemasson M, Levasseur-Moreau J, Manta S, Etievant A, Escoffier G, Doré FY, Roman FS, Beaulieu JM.

Neuropsychopharmacology. 2014 Apr;39(5):1125-34. doi: 10.1038/npp.2013.313. Epub 2013 Nov 7.

12.

Astrocytes and gliotransmitters: new players in the treatment of major depression?

Etiévant A, Lambás-Señas L, Scarna H, Lucas G, Haddjeri N.

Curr Drug Targets. 2013 Oct;14(11):1295-307. Review.

PMID:
24010966
13.

Dissociations between cognitive and motor effects of psychostimulants and atomoxetine in hyperactive DAT-KO mice.

Del'Guidice T, Lemasson M, Etiévant A, Manta S, Magno LA, Escoffier G, Roman FS, Beaulieu JM.

Psychopharmacology (Berl). 2014 Jan;231(1):109-22. doi: 10.1007/s00213-013-3212-8. Epub 2013 Aug 3.

PMID:
23912772
14.

Protein kinase C regulates mood-related behaviors and adult hippocampal cell proliferation in rats.

Abrial E, Etievant A, Bétry C, Scarna H, Lucas G, Haddjeri N, Lambás-Señas L.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jun 3;43:40-8. doi: 10.1016/j.pnpbp.2012.11.015. Epub 2012 Dec 8.

PMID:
23228462
15.

The rapid recovery of 5-HT cell firing induced by the antidepressant vortioxetine involves 5-HT(3) receptor antagonism.

Bétry C, Pehrson AL, Etiévant A, Ebert B, Sánchez C, Haddjeri N.

Int J Neuropsychopharmacol. 2013 Jun;16(5):1115-27. doi: 10.1017/S1461145712001058. Epub 2012 Oct 22.

PMID:
23089374
16.

Enhanced anxiety observed in cocaine withdrawn rats is associated with altered reactivity of the dorsomedial prefrontal cortex.

El Hage C, Rappeneau V, Etievant A, Morel AL, Scarna H, Zimmer L, Bérod A.

PLoS One. 2012;7(8):e43535. doi: 10.1371/journal.pone.0043535. Epub 2012 Aug 16.

17.

Synergistic antidepressant-like action of gaboxadol and escitalopram.

Christensen T, Bétry C, Mnie-Filali O, Etievant A, Ebert B, Haddjeri N, Wiborg O.

Eur Neuropsychopharmacol. 2012 Oct;22(10):751-60. doi: 10.1016/j.euroneuro.2012.02.001. Epub 2012 Mar 9.

PMID:
22406239
18.

In vivo effects of pardoprunox (SLV308), a partial D₂/D₃ receptor and 5-HT1A receptor agonist, on rat dopamine and serotonin neuronal activity.

Bétry C, Etiévant A, Lambás-Señas L, McCreary AC, Haddjeri N.

Synapse. 2011 Oct;65(10):1042-51. doi: 10.1002/syn.20936. Epub 2011 May 3.

PMID:
21446003
19.

Pharmacological blockade of 5-HT7 receptors as a putative fast acting antidepressant strategy.

Mnie-Filali O, Faure C, Lambás-Señas L, El Mansari M, Belblidia H, Gondard E, Etiévant A, Scarna H, Didier A, Berod A, Blier P, Haddjeri N.

Neuropsychopharmacology. 2011 May;36(6):1275-88. doi: 10.1038/npp.2011.13. Epub 2011 Feb 16.

20.

Bifeprunox and aripiprazole suppress in vivo VTA dopaminergic neuronal activity via D2 and not D3 dopamine autoreceptor activation.

Etievant A, Bétry C, Arnt J, Haddjeri N.

Neurosci Lett. 2009 Aug 21;460(1):82-6. doi: 10.1016/j.neulet.2009.05.035. Epub 2009 May 18.

PMID:
19450663

Supplemental Content

Loading ...
Support Center